TickrTrends EOLS fair value analysis

FDA Flags Evolus (EOLS) for Misleading Jeuveau Promotion on Instagram

gurufocus.com · 2026-10-02

On October 02, 2026, the U.S. Food and Drug Administration (FDA) contacted Evolus Inc (NASDAQ: EOLS) regarding concerns over a social media promotional post for

Read the full story at gurufocus.com →

Is EOLS undervalued? See TickrTrends' fair value analysis →